Literature DB >> 6620481

Talc and ovarian cancer.

P Hartge, R Hoover, L P Lesher, L McGowan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6620481

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.

Authors:  Anil Desphande; Gang Xia; LeeAnn J Boerma; Kimberly K Vines; Venkatram R Atigadda; Susan Lobo-Ruppert; Clinton J Grubbs; Fariba L Moeinpour; Craig D Smith; Konstantin Christov; Wayne J Brouillette; Donald D Muccio
Journal:  Bioorg Med Chem       Date:  2013-12-01       Impact factor: 3.641

2.  Risk factors for ovarian cancer: a case-control study.

Authors:  M Booth; V Beral; P Smith
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

3.  Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance.

Authors:  Triet H Tran; Joan E Steffen; Kate M Clancy; Tess Bird; David S Egilman
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

4.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

5.  Data on systematic review and meta-analysis of epidemiologic evidence on the association between perineal use of talc powder and risk of ovarian cancer.

Authors:  Mohamed Kadry Taher; Nawal Farhat; Nataliya A Karyakina; Nataliya Shilnikova; Siva Ramoju; Christopher A Gravel; Kannan Krishnan; Donald Mattison; Shi-Wu Wen; Daniel Krewski
Journal:  Data Brief       Date:  2020-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.